SNCA and synucleinopathy: The ability to detect disease-associated α-synuclein pathology in bodily fluids using SAA creates the possibility to detect neuropathology intra vitam, overcoming the considerable limitation of neuropathological assessment being the only method to definitively confirm the presence of cerebral α-synucleinopathy.